enVVeno Medical Corp (NVNO) has 12 open-market insider trades by 6 insiders since 2021. The most active filer is Robert Andrew Berman, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Francis Duhay | Dir | — | 3 | $549K | 2026-09-11 |
| Hamed Alavi | CTO | — | 1 | $104K | 2024-03-13 |
| Robert Andrew Berman | CEO | — | 4 | $71K | 2024-12-19 |
| Matthew Jenusaitis | Dir | — | 1 | $24K | 2024-12-19 |
| Sanjay Shrivastava | Dir | — | 2 | $20K | 2024-12-24 |
| Robert Gray | Dir | — | 1 | $10K | 2024-12-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Francis Duhay | Director | Sell | $123 | 2026-09-11 |
| Francis Duhay | Director | Sell | $1K | 2026-06-11 |
| Francis Duhay | Director | Sell | $2K | 2026-03-12 |
| Francis Duhay | Director | Sell | $2K | 2025-12-11 |
| Francis Duhay | Director | Sell | $4K | 2025-09-15 |
| Robert Gray | Director | Buy | $10K | 2024-12-31 |
Companies that share insiders with NVNO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Francis Duhay | Director | Buy | $500K | 2024-12-31 |
| Sanjay Shrivastava | Director | Buy | $16K | 2024-12-24 |
| Matthew Jenusaitis | Director | Buy | $24K | 2024-12-19 |
| Robert Andrew Berman | CEO | Buy | $31K | 2024-12-19 |
| Hamed Alavi | CTO | Sell | $104K | 2024-03-13 |
| Francis Duhay | Director | Buy | $48K | 2022-08-16 |
| Sanjay Shrivastava | Director | Buy | $4K | 2022-06-30 |
| Robert Andrew Berman | CEO | Buy | $10K | 2022-06-27 |
| Robert Andrew Berman | CEO | Buy | $15K | 2021-11-19 |